Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Dec-22 4:00 PM View:  | Wolfe Peter Chief Financial Officer | Zyversa Therapeutics, Inc. (ZVSA) | 16-Dec-22 | Grant | 3,000 | $2.88 | $8,644.50 | 7% 41.59K to 44.59K | |
| 14-Dec-22 7:21 PM View: | O'Connor Daniel Director 10% Owner | Zyversa Therapeutics, Inc. (ZVSA) | 12-Dec-22 | Acquisition (other) | 1,377,600 | -- | -- | 100% 0 to 1.38M | |
| 14-Dec-22 7:24 PM View: | Glover Steve C Chief Executive Officer Director | Zyversa Therapeutics, Inc. (ZVSA) | 12-Dec-22 | Grant | 448,909 | -- | -- | 100% 0 to 448.91K | |
| 14-Dec-22 7:37 PM View: | Wolfe Peter Chief Financial Officer | Zyversa Therapeutics, Inc. (ZVSA) | 12-Dec-22 | Grant | 41,585 | -- | -- | 100% 0 to 41.59K | |
| 14-Dec-22 7:24 PM View: | Glover Steve C Chief Executive Officer Director | Zyversa Therapeutics, Inc. (ZVSA) | 12-Dec-22 | Grant | 178,925 | -- | -- | 40% 448.91K to 627.83K | |
| 16-Dec-22 9:41 PM View: | Incon Co., Ltd. 10% Owner | Zyversa Therapeutics, Inc. (ZVSA) | 12-Dec-22 | Grant | 1,497,200 | -- | -- | 100% 0 to 1.5M | |
| 14-Dec-22 7:31 PM View: | Labella Nicholas A. Jr. Chief Scientific Officer | Zyversa Therapeutics, Inc. (ZVSA) | 12-Dec-22 | Grant | 18,094 | -- | -- | 100% 0 to 18.09K | |
| 08-Mar-22 1:51 PM View: | A.G.P. / Alliance Global Pa... 10% Owner | Zyversa Therapeutics, Inc. (ZVSA) | 08-Mar-22 | Disposition (other) | 3,427 | -- | -- | (< 1%) 450.27K to 446.84K | |
| 07-Feb-22 7:36 PM View: | A.G.P. / Alliance Global Pa... 10% Owner | Zyversa Therapeutics, Inc. (ZVSA) | 03-Feb-22 | Disposition (other) | 49,730 | -- | -- | (10%) 500.0K to 450.27K | |
| 10-Mar-22 5:32 PM View: | Larkspur Health LLC 10% Owner | Zyversa Therapeutics, Inc. (ZVSA) | 06-Jan-22 | Acquisition (other) | 236,273 | -- | -- | 100% 0 to 236.27K | |
| 10-Mar-22 5:30 PM View: | Briones David S. Chief Financial Officer Director | Zyversa Therapeutics, Inc. (ZVSA) | 06-Jan-22 | Acquisition (other) | 10,752 | -- | -- | 100% 0 to 10.75K | |
| 10-Mar-22 5:31 PM View: | O'Connor Daniel Chief Executive Officer Director | Zyversa Therapeutics, Inc. (ZVSA) | 06-Jan-22 | Acquisition (other) | 42,005 | -- | -- | 100% 0 to 42.01K |
